Abstract:Inflammatory bowel disease-related colorectal cancer (IBD-CRC) is one of the most serious complications of IBD contributing to significant mortality in this cohort of patients. IBD is often associated with diet and lifestyle-related gut microbial dysbiosis, the interaction of genetic and environmental factors, leading to chronic gut inflammation. According to the "common ground hypothesis", microbial dysbiosis and intestinal barrier impairment are at the core of the chronic inflammatory process associated with IBD-CRC. Among the many underlying factors known to increase the risk of IBD-CRC, perhaps the most important factor is chronic persistent inflammation. The persistent inflammation in the colon results in increased proliferation of cells necessary for repair but this also increases the risk of dysplastic changes due to chromosomal and microsatellite instability. Multiple pathways have been identified, regulated by many positive and negative factors involved in the development of cancer, which in this case follows the 'inflammation-dysplasia-carcinoma' sequence. Strategies to lower this risk are extremely important to reduce morbidity and mortality due to IBD-CRC, among which colonoscopic surveillance is the most widely accepted and implemented modality, forming part of many national and international guidelines. However, the effectiveness of surveillance in IBD has been a topic of much debate in recent years for multiple reasons - cost-benefit to health systems, resource requirements, and also because of studies showing conflicting long-term data. Our review provides a comprehensive overview of past, present, and future perspectives of IBD-CRC. We explore and analyse evidence from studies over decades and current best practices followed globally. In the future directions section, we cover emerging novel endoscopic techniques and artificial intelligence that could play an important role in managing the risk of IBD-CRC.

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications

Endoscopic approaches to the management of dysplasia in inflammatory bowel disease: A state-of-the-art narrative review

Colorectal Neoplasia in the Setting of Inflammatory Bowel Disease

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives

Colorectal cancer in inflammatory bowel disease: review of the evidence

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines

Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD

Inflammatory Bowel Disease and Colorectal Cancer

Colitis-associated neoplasia: molecular basis and clinical translation

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy

Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease – the Evolving Landscape

Risk of Colorectal Cancer in Inflammatory Bowel Diseases

Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study.

Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis

Colorectal Cancer In Inflammatory Bowel Disease: Epidemiology, Pathogenesis And Surveillance